Partnering Solutions

  1. Greenphire Clinical Finance Suite: Site Payments 9/16/2025

    Automate and simplify complex global investigator payments with a proven solution used across 80+ countries.

  2. Executing Bladder Cancer Trials In A Complex Clinical Landscape 3/5/2026

    Successfully navigating the complexities of bladder cancer research means mastering specialized delivery methods, managing supply constraints, and leveraging deep site relationships across all phases.

  3. Are You Preparing For First-In-Human Clinical Trials? 8/7/2026

    Reach critical first-in-human milestones faster with experienced teams, rapid study start-up, and real-time data that reduce complexity, inform decisions, and de-risk development.

  4. Transforming Clinical Trial Site Forecasting 10/30/2024

    In today’s ever-evolving clinical trial space, managing the expenses associated with conducting a study is more important – and fraught – than ever before.

  5. Isotope Labelling 3/3/2022

    Whether you need isotopically labelled (14C/SIL) compounds for nonclinical or clinical metabolism studies and the quantification of materials in biological matrices, our expertise provides the necessary labelled materials tailored to support your studies.

  6. Your Top Partner For Ophthalmic Drug Development 4/9/2024

    As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.

  7. Proven Expertise With Global Solutions For U.S. Biotechs 1/7/2025

    The success of a biotech drug development program often depends on the relationship it forms with its Clinical Research Organization (CRO) partner.

    Avance Clinical, a global CRO with more than 3 decades of experience, has an impressive track record in the US with over 200 US studies including 140 in oncology.

  8. An Experienced Endocrinology And Metabolic Partner 7/13/2026

    Accelerate endocrinology and metabolic trials. Discover global regulatory strategies, decentralized models, and patient-centric recruitment data to optimize your clinical development.

  9. Advancing Development And Approval Of Rare/Ultra-Rare Disease Therapies 5/8/2024

    Veristat empowers rare disease therapy with science-driven strategies and trusted expertise, supporting over 350 rare disease projects and preparing 40+ marketing applications in the past five years.

  10. Central Nervous System Drug Development 1/16/2026

    CNS drug development faces unique hurdles — from high placebo response to complex protocols and recruitment challenges. Discover strategies to streamline trials, optimize planning, and accelerate delivery of innovative therapies for patients with critical unmet needs.